Literature DB >> 10504225

Crystal structures of alpha-mercaptoacyldipeptides in the thermolysin active site: structural parameters for a Zn monodentation or bidentation in metalloendopeptidases.

J F Gaucher1, M Selkti, G Tiraboschi, T Prangé, B P Roques, A Tomas, M C Fournié-Zaluski.   

Abstract

Three alpha-mercaptoacyldipeptides differing essentially in the size of their C-terminal residues have been crystallized in the thermolysin active site. A new mode of binding was observed for 3 [HS-CH(CH(2)Ph)CO-Phe-Tyr] and 4 [HS-CH((CH(2))(4)CH(3))CO-Phe-Ala], in which the mercaptoacyl moieties act as bidentates with Zn-S and Zn-O distances of 2.3 and 2.4 A, respectively, the side chains fitting the S(1), S(1)', and S(2)' pockets. Moreover, a distance of 3.1 A between the sulfur atom and the OE1 of Glu(143) suggests that they are H-bonded and that one of these atoms is protonated. This H-bond network involving Glu(143), the mercaptoacyl group of the inhibitor, and the Zn ion could be considered a "modified" transition state mimic of the peptide bond hydrolysis. Due to the presence of the hindering (5-phenyl)proline, the inhibitor HS-CH(CH(2)Ph)CO-Gly-(5-Ph)Pro (2) interacts through the usual Zn monodentation via the thiol group and occupancy of S(1)' and S(2)' subsites by the aromatic moieties, the proline ring being outside the active site. The inhibitory potencies are consistent with these structural data, with higher affinities for 3 (4.2 x 10(-)(8) M) and 4 (4.8 x 10(-)(8) M) than for 2 (1.2 x 10(-)(6) M). The extension of the results, obtained with thermolysin being considered as the model of physiological zinc metallopeptidases, allows inhibitor-recognition modes for other peptidases, such as angiotensin converting enzyme and neutral endopeptidase, to be proposed and opens interesting possibilities for the design of new classes of inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504225     DOI: 10.1021/bi991043z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP.

Authors:  Yogendra Patel; Valerie J Gillet; Gianpaolo Bravi; Andrew R Leach
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

2.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

3.  Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity.

Authors:  Davide M Ferraris; Diego Sbardella; Agnese Petrera; Stefano Marini; Beat Amstutz; Massimo Coletta; Peter Sander; Menico Rizzi
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

4.  Homology modeling of hemagglutinin/protease [HA/P (vibriolysin)] from Vibrio cholerae: sequence comparision, residue interactions and molecular mechanism.

Authors:  Ghosia Lutfullah; Farhat Amin; Zahid Khan; Noreen Azhar; M Kamran Azim; Sajid Noor; Khalida Shoukat
Journal:  Protein J       Date:  2008-02       Impact factor: 2.371

5.  QM/MM investigation of the catalytic mechanism of angiotensin-converting enzyme.

Authors:  Xia Mu; Chunchun Zhang; Dingguo Xu
Journal:  J Mol Model       Date:  2016-05-16       Impact factor: 1.810

6.  Stimulation and oxidative catalytic inactivation of thermolysin by copper.Cys-Gly-His-Lys.

Authors:  Nikhil H Gokhale; Seth Bradford; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2007-07-06       Impact factor: 3.358

7.  Metallotherapeutics: novel strategies in drug design.

Authors:  Lalintip Hocharoen; James A Cowan
Journal:  Chemistry       Date:  2009-09-07       Impact factor: 5.236

8.  'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site.

Authors:  David P Martin; Patrick G Blachly; Amy R Marts; Tessa M Woodruff; César A F de Oliveira; J Andrew McCammon; David L Tierney; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2014-03-27       Impact factor: 15.419

9.  Exploring the influence of the protein environment on metal-binding pharmacophores.

Authors:  David P Martin; Patrick G Blachly; J Andrew McCammon; Seth M Cohen
Journal:  J Med Chem       Date:  2014-08-19       Impact factor: 7.446

10.  Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme.

Authors:  Urvashi Sharma; Gyles E Cozier; Edward D Sturrock; K Ravi Acharya
Journal:  J Med Chem       Date:  2020-05-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.